UnknownNot Applicable

Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease

China50 participantsStarted 2023-03-01

Plain-language summary

Determination of IRTI (infrared thermal imaging) can be used to evaluate PAD patients with critical limb ischemia with different degrees of lesion. IRTI can be used to evaluate the foot blood perfusion after percutaneous transluminal angioplasty (PTA) treatment and determine the success rate of surgery. IRTI can be used as an effective follow-up tool for patients after surgery.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Rutherford grade 3, 4, 5, or 6. * Patients with indications for lower extremity arterial PTA: severe intermittent claudication, rest pain, ulceration or gangrene. * Patients who required PTA of only one limb (left versus right). Exclusion Criteria: * Patients with body temperature above 37 ° C. * Patients with indications for open surgery. * Patients requiring major amputation (above the ankle). * Patients with acute occlusive or embolic limb ischemia. * Patients with deep venous thrombosis of the lower extremity.

What they're measuring

To determine the validity and reliability of IRTI in assessing foot blood perfusion and surgical success rate after PTA treatment.

Timeframe: up to 15 months

Trial details

NCT IDNCT05941533

SponsorFangge Deng

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More Peripheral Artery Disease (PAD) trials